https://scholars.lib.ntu.edu.tw/handle/123456789/634976
標題: | Efficacy and Tolerability of Ramucirumab Plus Erlotinib in Taiwanese Patients with Untreated, Epidermal Growth Factor Receptor-Mutated, Stage IV Non-small Cell Lung Cancer in the RELAY Study | 作者: | Chiu, Chao-Hua Lin, Meng-Chih Wei, Yu-Feng Chang, Gee-Chen Su, Wu-Chou Hsia, Te-Chun Su, Jian Wang, Anne Kuei-Fang Jen, Min-Hua Puri, Tarun JIN-YUAN SHIH |
公開日期: | 七月-2023 | 卷: | 18 | 期: | 4 | 來源出版物: | Targeted oncology | 摘要: | In RELAY, a randomized, double-blind, phase III trial investigating the efficacy and safety of ramucirumab+erlotinib (RAM+ERL) or ERL+placebo (PBO) in patients with untreated, stage IV, epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC), RAM+ERL demonstrated superior progression-free survival (PFS) versus PBO+ERL, with no new safety signals. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/634976 | ISSN: | 17762596 | DOI: | 10.1007/s11523-023-00975-5 |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。